- Home
- HBIO vs LICN Comparison
HBIO vs LICN Comparison
Compare HBIO & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- LICN
- Stock Information
- Founded
- HBIO 1901
- LICN 2004
- Country
- HBIO United States
- LICN China
- Employees
- HBIO N/A
- LICN N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- LICN
- Sector
- HBIO Industrials
- LICN
- Exchange
- HBIO Nasdaq
- LICN Nasdaq
- Market Cap
- HBIO 93.3M
- LICN 83.8M
- IPO Year
- HBIO 2000
- LICN 2023
- Fundamental
- Price
- HBIO $2.19
- LICN $0.17
- Analyst Decision
- HBIO
- LICN
- Analyst Count
- HBIO 0
- LICN 0
- Target Price
- HBIO N/A
- LICN N/A
- AVG Volume (30 Days)
- HBIO 163.5K
- LICN 21.2M
- Earning Date
- HBIO 11-07-2024
- LICN 12-24-2024
- Dividend Yield
- HBIO N/A
- LICN N/A
- EPS Growth
- HBIO N/A
- LICN 36.90
- EPS
- HBIO N/A
- LICN 0.28
- Revenue
- HBIO $97,732,000.00
- LICN $41,929,000.00
- Revenue This Year
- HBIO N/A
- LICN N/A
- Revenue Next Year
- HBIO $4.32
- LICN N/A
- P/E Ratio
- HBIO N/A
- LICN $0.61
- Revenue Growth
- HBIO N/A
- LICN 24.86
- 52 Week Low
- HBIO $1.99
- LICN $0.15
- 52 Week High
- HBIO $5.56
- LICN $2.44
- Technical
- Relative Strength Index (RSI)
- HBIO 42.95
- LICN 19.85
- Support Level
- HBIO $2.07
- LICN $0.15
- Resistance Level
- HBIO $2.32
- LICN $0.19
- Average True Range (ATR)
- HBIO 0.12
- LICN 0.23
- MACD
- HBIO -0.00
- LICN -0.13
- Stochastic Oscillator
- HBIO 22.58
- LICN 0.65
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About LICN Lichen China Limited
Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.